Who Owns RoC?

RoC operates within Bridgepoint's corporate framework, which includes sustainable growth initiatives. As a skincare brand with pharmaceutical heritage, RoC maintains rigorous standards for product safety, clinical testing, and environmental responsibility.

The brand's French pharmacy origins influence its approach to skincare development, with a foundation in hypoallergenic formulations that prioritize skin health. RoC's products undergo extensive clinical testing to validate efficacy claims, a practice more common in pharmaceutical development than cosmetics.

RoC does not hold independent sustainability certifications such as B Corp. The brand's environmental practices are governed by its own corporate policies rather than third-party frameworks. In 2025, RoC announced plans to achieve carbon-neutral manufacturing by 2028 through renewable energy implementation at contract manufacturing facilities and carbon offset programs.

RoC's manufacturing processes adhere to FDA and international cosmetics regulations across its global operations. The company has implemented initiatives to reduce environmental impact in packaging and production while maintaining the clinical efficacy of its anti-aging formulations.

The brand's focus on clinically proven ingredients and precise concentration calibration reduces waste while delivering results, supporting more sustainable consumption patterns. RoC maintains strict ingredient sourcing and testing protocols to ensure product safety and regulatory compliance.

RoC has received significant recognition from beauty magazines, editors, and industry organizations for its clinically proven skincare products. The brand maintains a dedicated "Award Winners" collection showcasing its most recognized formulations.

RoC's innovation in retinol stabilization technology, dating to the 1990 launch of RETINOL Actif Pur, has been acknowledged by dermatologists and skincare professionals as a significant advancement in accessible anti-aging treatments. The brand was the first to make pharmaceutical-grade retinol available in over-the-counter formulations.

RoC has been recognized as America's number one retinol brand, with 21 consecutive quarters of market share gains in the United States according to NielsenIQ. The brand outperformed L'Oreal and Neutrogena as the top-selling retinol brand for the year ended April 2024.

In 2025, RoC's eye balm gained viral attention, with media reports noting that one is sold every 20 seconds. The brand's products have been featured in TODAY's Shop Mature Beauty Awards and recognized by the Global Makeup Awards.

RoC's 70 percent revenue growth between 2020 and 2024 has been acknowledged by business analysts as demonstrating strong brand positioning and consumer demand for effective skincare solutions. The brand reclaimed the number one position in eye cream in the United States.

RoC has maintained a strong safety record throughout its 68-year history, with no major product recalls or significant safety incidents reported. The brand's pharmaceutical heritage and rigorous clinical testing processes have contributed to its reputation for product safety and efficacy.

The skincare industry has faced increased regulatory scrutiny regarding product claims and ingredient safety, particularly around retinol formulations. In 2025, the FDA published draft guidance explaining its mandatory recall authority for cosmetic products, reflecting increased regulatory oversight. RoC has not been subject to mandatory recalls and has proactively adapted to evolving regulatory requirements.

The cosmetics industry has faced broader controversies related to ingredient safety, particularly concerning talc contamination and asbestos testing. While these issues have primarily affected other companies, RoC has maintained strict ingredient sourcing and testing protocols to ensure product safety.

RoC's ownership transitions, including the 2019 sale by J&J to Gryphon Investors and the 2024 acquisition by Bridgepoint, have proceeded without major controversies. These changes have been positioned as strategic opportunities for brand growth rather than problematic divestitures.

The brand has not faced significant consumer controversies related to product efficacy or safety claims. RoC's commitment to clinical testing and dermatologist partnerships has helped maintain consumer trust in the crowded skincare market.